# Patient-Centered Outcomes Research Institute (PCORI) - Funder Profile

**Last Updated**: 2026-02-03
**Research Conducted By**: grant-funder-researcher agent
**Primary Sources**: PCORI Official Website, PCORI Funding Announcements, PCORI Portfolio Database

---

## Organization Overview

| Field | Value |
|-------|-------|
| **Organization Name** | Patient-Centered Outcomes Research Institute (PCORI) |
| **Organization Type** | Independent Nonprofit Research Organization |
| **Congressional Authorization** | 2010 (Affordable Care Act) |
| **Reauthorization** | December 2019 (expanded focus areas) |
| **Geographic Focus** | United States (national scope) |
| **Annual Funding Capacity** | ~$500-600 million |
| **Award Range** | $100,000 - $30,000,000 (varies by program) |
| **EIN** | Not applicable (independent nonprofit, not a private foundation) |
| **Website** | https://www.pcori.org |
| **Headquarters** | 1333 New Hampshire Avenue NW, Suite 1200, Washington, DC 20036 |
| **Phone** | (202) 827-7700 |
| **Email** | info@pcori.org |

---

## Mission & Priorities

### Mission Statement

> "PCORI funds patient-centered comparative clinical effectiveness research (CER) that helps people make informed healthcare decisions and improves healthcare delivery and outcomes. Our research compares the benefits and potential harms of different healthcare options, generating evidence that empowers patients, caregivers and other healthcare decision makers."

*Source: https://www.pcori.org (Retrieved: 2026-02-03)*

### Core Purpose

PCORI's tagline is **"Research Done Differently"**, emphasizing meaningful patient and stakeholder engagement throughout the research process. The organization was established by Congress to fund comparative clinical effectiveness research that:

- Produces patient-relevant evidence
- Involves patients as equitable partners in all phases of research
- Compares two or more healthcare interventions or approaches
- Addresses questions important to patients and healthcare decision-makers

### National Priorities for Health

1. **Achieve Health Equity** - Primary guiding priority across all funding programs
2. **Comparative Clinical Effectiveness** - Core research focus
3. **Patient-Centered Research** - Foundational methodological approach

### Strategic Priority Areas

1. **Mental and Behavioral Health**: Depression, anxiety, substance use disorders, integrated care models
   - Largest share of PCORI portfolio (414 projects, ~$785M)
   - Focus on treatment comparisons, care delivery models, and prevention strategies

2. **Cardiovascular Diseases**: Heart disease, hypertension, stroke prevention and treatment
   - 226 funded projects (~$430M)
   - Emphasis on medication comparisons, lifestyle interventions, and care coordination

3. **Cancer**: Treatment comparisons, survivorship care, screening strategies
   - 223 funded projects (~$425M)
   - Growing focus on patient-reported outcomes and quality of life

4. **Maternal Morbidity and Mortality**: Pregnancy care, postpartum support, disparities reduction
   - Designated priority area since 2019 reauthorization
   - Special emphasis on health equity and SDOH interventions

5. **Intellectual and Developmental Disabilities (IDD)**: Care access, quality improvement, community integration
   - Designated priority area since 2019 reauthorization
   - Focus on systems-level strategies and care navigation

6. **Obesity Treatment and Management**: Lifestyle interventions, medications, procedures, bariatric surgery
   - Special Area of Emphasis for 2026 Cycle 1
   - Preference for objective, clinically meaningful outcomes

7. **Chronic Conditions**: Diabetes, respiratory diseases, kidney disease, neurological disorders
   - Combined 510+ projects across nutritional/metabolic and respiratory categories
   - Emphasis on self-management, care coordination, and prevention

8. **Pain Management**: Chronic pain treatment, opioid alternatives, integrated approaches
   - $100 million committed funding focus
   - Priority on non-pharmacological interventions

9. **Rare Diseases**: Treatment comparisons, care delivery, patient registries
   - Growing portfolio area
   - Emphasis on patient engagement in rare disease research

10. **Sensory Health**: Vision, hearing, balance across the lifespan
    - New dedicated funding opportunity for 2026
    - Focus on prevention, treatment, and technology interventions

### Special Focus: AI/ML Methods for CER

PCORI has identified **Methods to Improve the Use of Artificial Intelligence (AI) and Machine Learning (ML) in CER** as a key methodological priority for 2025-2026, including:
- AI/ML applications to augment or transform research methodologies
- AI/ML approaches to enhance health communication
- Development and validation of AI/ML methods for comparative effectiveness research
- Up to $750,000 per project, 3-year duration

### Target Populations

- Patients and caregivers across all health conditions
- Underserved and vulnerable populations experiencing health disparities
- Racial and ethnic minority communities
- Rural and urban underserved communities
- People with intellectual and developmental disabilities
- Maternal health populations at high risk
- Older adults and people with chronic conditions
- Children and adolescents

---

## Leadership & Governance

### Executive Leadership

| Name | Title | Background |
|------|-------|------------|
| Nakela L. Cook, M.D., MPH | Executive Director | Cardiologist and health services researcher; M.D. from Harvard Medical School; M.P.H. in Health Care Policy and Management from Harvard School of Public Health; Former Senior Scientific Officer and Chief of Staff, NHLBI/NIH; Named among Modern Healthcare's "100 Most Influential People in Healthcare" (2024) |
| Harv Feldman, M.D., MSCE | Deputy Executive Director for Patient-Centered Research Programs | Oversees research program portfolio |
| Carolyn Best, Ph.D. | Chief Officer, Program Operations | Manages operational aspects of research programs |
| Erin Holve, Ph.D., MPP, MPH | Chief Officer, Research Infrastructure and Innovation | Leads PCORnet and research infrastructure initiatives |

*Source: https://www.pcori.org/about (Retrieved: 2026-02-03)*

### Board of Governors

| Position | Name | Appointed By | Term |
|----------|------|-------------|------|
| Chairperson | Russell M. Howerton | GAO | September 2025 |
| Vice Chairperson | Jennifer DeVoe | GAO | September 2025 |

**Board Committees:**
- Strategy Committee
- Standing Selection Committee
- Nominating Committee
- Governance Committee
- Finance and Administration Committee
- Executive Evaluation and Compensation Committee
- Executive Committee

### Methodology Committee

PCORI maintains an active Methodology Committee responsible for:
- Developing and endorsing methodology standards (67 standards across 17 areas)
- Reviewing methodology standards updates
- Providing guidance on research methods for CER

---

## FIU Prior Relationship

| Field | Value |
|-------|-------|
| **Prior Grant History** | No direct awards to FIU or NeighborhoodHELP |
| **Relationship Strength** | Pipeline - High priority target |
| **Florida Presence** | 85+ funded projects statewide; University of Florida Health System is HSII Capacity Building participant |

### Leverage Points

- **Health Equity Focus**: NeighborhoodHELP's service to underserved Miami-Dade communities aligns with PCORI's National Priority to Achieve Health Equity
- **Patient Engagement Model**: NeighborhoodHELP's community-driven approach with Community Health Workers demonstrates the meaningful engagement PCORI requires
- **AI/ML Innovation**: FIU Thrive's AI-enhanced SDOH screening aligns with PCORI's Methods PFA priority on AI/ML applications
- **Comparative Effectiveness Design**: FIU Thrive-enhanced care vs. standard care creates natural comparative framework PCORI requires
- **SDOH Research**: Growing body of PCORI-funded CHW and patient navigation studies provides precedent for proposed approach
- **Pragmatic Implementation**: Real-world delivery through mobile health platform fits PCORI's pragmatic study preferences

### Relationship Building Strategy

1. **Engagement Award First**: Apply for Capacity Building Engagement Award ($100K-$300K) to establish patient advisory board and build relationship with PCORI program officers
2. **Program Officer Consultation**: Engage PCORI staff before LOI submission to discuss concept fit and receive guidance
3. **Methods PFA Entry**: Consider AI/ML Methods proposal to validate FIU Thrive methodology ($500K-$750K)
4. **Major Research Award**: Submit Broad Pragmatic Studies application after establishing foundation (Category 1: up to $5M or Category 2: $5M-$12M)

### Key Contacts

| Name | Title | Contact Info | Notes |
|------|-------|--------------|-------|
| General Inquiries | - | info@pcori.org, (202) 827-7700 | First point of contact |
| Funding Opportunities Team | Program Staff | pfa@pcori.org | Questions about specific funding announcements |
| Engagement Resources Team | - | Via website forms | Support for patient engagement planning |

**Action Items:**
- [ ] Contact pfa@pcori.org to request program officer consultation
- [ ] Sign up for PCORI funding alerts at https://www.pcori.org/funding-opportunities
- [ ] Attend PCORI virtual town hall for Cycle 2 2026 opportunities

---

## Application Process

### Application Type

**Two-Stage Process (LOI Required)**
- Stage 1: Letter of Intent (LOI) - Required for all research programs
- Stage 2: Full Application (Invitation Only) - Only invited LOIs may submit

### Application Timeline (2026 Cycle 2 - TARGET)

| Stage | Timing |
|-------|--------|
| **Funding Announcement Opens** | April 1, 2026 |
| **LOI Deadline** | April 28, 2026 (5:00 PM ET) |
| **LOI Review Period** | May-June 2026 |
| **Invitation to Full Application** | Late June/Early July 2026 |
| **Full Application Deadline** | September 1, 2026 (5:00 PM ET) |
| **Merit Review Period** | September-November 2026 |
| **Decision Notification** | December 2026 (typical) |
| **Award/Funding Start** | March-April 2027 (estimated) |

**Note:** Cycle 1 2026 LOI deadline (January 6, 2026) has passed. FIU is targeting Cycle 2.

### Application Portal

**PCORI Online**: https://pcori.force.com/s/
- Single submission system for all PCORI funding applications
- Requires account creation and institutional registration
- Templates and forms available for download before submission

### Critical Requirements

- [x] **Comparative Design**: Must compare two or more interventions, strategies, or approaches
- [x] **Patient Engagement**: Meaningful engagement of patients and stakeholders throughout all phases (planning, conduct, dissemination)
- [x] **Patient-Centered Outcomes**: Primary outcomes must be important to patients and reflect patient experiences
- [x] **Methodology Standards Compliance**: Must adhere to applicable PCORI Methodology Standards (67 standards across 17 areas)
- [x] **U.S. Focus**: Research must be conducted in the United States
- [x] **Institutional Eligibility**: Public/private nonprofit organizations, academic institutions, healthcare systems; no federal agencies
- [x] **Budget Justification**: Must justify budget relative to program category limits
- [x] **Engagement Budget**: Must budget for patient/stakeholder compensation and engagement activities
- [x] **IRB/Ethics Approval**: Must obtain appropriate ethical approvals before award
- [x] **No QALYs**: Cost-effectiveness analyses using quality-adjusted life-years (QALYs) are prohibited

### Six Foundational Expectations for Partnerships

PCORI's engagement requirements are **non-negotiable**. Applications that do not meet these expectations will be deemed nonresponsive and not reviewed:

1. **Representative Involvement**: Include partners who reflect the range of patients and communities affected by the research
2. **Early & Ongoing Engagement**: Partners contribute throughout all phases (planning, conducting, disseminating)
3. **Dedicated Funds for Engagement & Partner Compensation**: Budget for engagement activities and compensate partners for their expertise
4. **Build Capacity to Work as a Team**: Provide training, support, and resources for collaborative work
5. **Meaningful Inclusion in Decision Making**: Implement structures that include partners in decision making
6. **Ongoing Review & Assessment**: Gather feedback throughout the project to improve engagement approaches

**What Does NOT Qualify:**
- Input-only activities (surveys, focus groups without decision-making role)
- Token involvement without authority
- Late-stage consultation only

---

## Decision Making

### Review Process

**Multi-Stage Merit Review:**

1. **LOI Review (Staff)**
   - PCORI program staff review all LOIs
   - Assess alignment with funding announcement priorities
   - Evaluate preliminary patient engagement plan
   - Invite approximately 30-40% to full application

2. **Preliminary Online Review (Merit Review Panel)**
   - Scientific reviewers, patient representatives, and stakeholder representatives
   - Independent scoring on 9-point scale
   - All reviewer types have equal voting weight
   - Preliminary scores determine which applications advance to in-person discussion

3. **In-Person Panel Discussion**
   - Subset of applications discussed in detail
   - Panel reaches consensus scores
   - Generates written critiques and recommendations

4. **Post-Panel Review**
   - PCORI program staff review panel recommendations
   - Assessment of portfolio balance and strategic priorities
   - Verification of methodology standards compliance

5. **Selection Committee Recommendation**
   - Standing Selection Committee reviews staff recommendations
   - Makes funding recommendations to Executive Director

6. **Executive Director Approval**
   - Final funding decisions by Executive Director
   - Public announcement of awards

### Review Criteria

Applications are evaluated against six merit review criteria:

1. **Scientific and Technical Merit**
   - Significance of research question
   - Rigor of study design and methods
   - Appropriateness of comparators
   - Feasibility of implementation

2. **Patient-Centeredness**
   - Relevance to patient decision-making
   - Patient-important outcomes
   - Incorporation of patient preferences and values
   - Diversity and representativeness

3. **Patient and Stakeholder Engagement**
   - Meaningfulness of engagement throughout project
   - Adherence to Six Foundational Expectations
   - Partner compensation and capacity building
   - Governance and decision-making structures

4. **Methods and Analyses**
   - Adherence to applicable PCORI Methodology Standards
   - Rigor of statistical and analytical approaches
   - Data management and integrity
   - Handling of missing data and heterogeneity

5. **Team and Environment**
   - Qualifications and expertise of investigators
   - Adequacy of resources and facilities
   - Institutional commitment and support
   - Previous PCORI engagement or research experience

6. **Potential for Impact**
   - Likelihood of improving patient outcomes
   - Contribution to health equity
   - Dissemination and implementation potential
   - Scalability and generalizability

### Scoring System

**9-Point Scale (Lower is Better):**
- **1-3**: Minor weaknesses (fundable range)
- **4-6**: Moderate weaknesses
- **7-9**: Major weaknesses (not fundable)

### Decision Timeline

- **LOI to Full Application Invitation**: 8-10 weeks
- **Full Application to Decision**: 3-4 months
- **Overall Timeline**: 12-18 months from LOI to award start

### Award Notification

- Email notification to Principal Investigator and institutional authorized official
- Public announcement on PCORI website
- Press release for major awards
- Award letter with terms and conditions

---

## Funding Programs & Award Characteristics

### Broad Pragmatic Studies (BPS)

**Award Amounts:**
| Category | Direct Costs | Duration | Description |
|----------|--------------|----------|-------------|
| Category 1 | Up to $5 million | Up to 5 years | Standard pragmatic research projects |
| Category 2 | $5 - $12 million | Up to 5 years | Large-scale studies requiring strong justification |
| Category 3 | $12 - $30 million | Up to 5 years | PCORnet-based national-scale studies (requires 2+ Clinical Research Networks) |

**Total Available (Cycle 2 2026)**: $120 million (estimated)

**Special Areas of Emphasis (varies by cycle)**:
- Obesity treatment and management
- Menopausal symptoms
- IDD care delivery
- Community health worker interventions
- SDOH screening and navigation

### Phased Large Awards for Comparative Effectiveness Research (PLACER)

**Award Structure:**
| Phase | Maximum | Duration | Purpose |
|-------|---------|----------|---------|
| Feasibility Phase | $2 million | 18 months | Planning, pilot testing, infrastructure development |
| Full-Scale Phase | $20 million | Up to 5 years | Large-scale pragmatic trial |
| Total Maximum | $22 million | ~6.5 years | Complete phased project |

**Total Available (Cycle 2 2026)**: $120 million (estimated)

**Requirements**: Minimum expected budget >$12 million direct costs; must justify need for phased approach

### Retrospective Observational Studies

**Award Characteristics:**
- Maximum Direct Costs: $2 million
- Maximum Duration: 18 months
- Focus: Secondary analysis of existing data
- Specific Health Topics: Cancer, Pain, Substance Use, Maternal Health, IDD, Sensory Health, Metabolic/Endocrine, Mental Health, Rare Diseases

### Improving Methods for Patient-Centered CER (Methods PFA)

**Award Characteristics:**
- Maximum Direct Costs: $750,000
- Maximum Duration: 3 years
- Total Available (per cycle): $12 million
- **2026 Priority**: AI/ML Methods for CER

**Examples of Fundable Projects:**
- Validation of AI/ML algorithms for patient-reported outcomes
- Methods for transparent AI/ML model interpretation
- AI-enhanced approaches to patient engagement
- Novel methods for analyzing patient-generated data

### Engagement Awards

| Award Type | Maximum Amount | Duration | Purpose |
|------------|----------------|----------|---------|
| Capacity Building | $300,000 (total costs) | Up to 2 years | Build organizational capacity for patient-centered research |
| Dissemination Initiative | $300,000 (total costs) | Up to 2 years | Spread research findings to patients and stakeholders |
| Small Organizations | $100,000 | Up to 2 years | Support engagement activities for organizations with budgets <$1M |

**Total FY2026 Engagement Awards**: Up to $25 million

**Note**: Excellent entry point for FIU to establish patient advisory board and PCORI relationship

### Budget Policies

**Indirect Cost Rate**: Maximum 40% of allowable direct costs
- Foreign organizations: Maximum 10%
- Organizations without federal rate: May request up to 10%
- Base exclusions: Equipment, patient care costs, subcontractor costs >$25,000

**Personnel Limits**:
- Salary cap: $200,000 annual institutional base salary
- No cap on fringe benefits

**Equipment**: Items >$5,000 allowed with justification

**Patient Care Costs**: Requests >15% of research budget require strong justification

**DSMB Expenses**: Limited to 2% of total direct costs

**Cost Sharing**: Not required (but in-kind contributions can be noted)

---

## Historical Giving Patterns

### Portfolio Overview (as of 2025)

| Metric | Value |
|--------|-------|
| **Total Projects Funded** | 2,621+ |
| **Total Funding Awarded** | $5+ billion (since 2010) |
| **Average Award Size** | ~$1.9 million |
| **Completed Projects** | 1,922 (73.3%) |
| **Ongoing Projects** | 534 (20.4%) |
| **Projects in Peer Review** | 38 (1.5%) |

*Source: https://www.pcori.org/explore-our-portfolio (Retrieved: 2026-02-03)*

### Funding by Category

| Category | Projects | Percentage |
|----------|----------|------------|
| Engagement in Research | 1,295 | 49.4% |
| Research | 1,019 | 38.9% |
| Dissemination & Implementation | 154 | 5.9% |
| Research Infrastructure (PCORnet) | 124 | 4.7% |
| Other Evidence Products | 29 | 1.1% |

### Geographic Distribution (Top 10 States)

| Rank | State | Projects |
|------|-------|----------|
| 1 | California | 290 |
| 2 | Massachusetts | 245 |
| 3 | Pennsylvania | 203 |
| 4 | Maryland | 147 |
| 5 | New York | 140+ |
| 6 | Texas | 120+ |
| 7 | North Carolina | 110+ |
| 8 | Illinois | 100+ |
| 9 | Colorado | 90+ |
| 10 | **Florida** | **85+** |

**Florida Note**: University of Florida Health System is an HSII (Health Systems Implementation Initiative) Capacity Building participant. Multiple implementation projects include Florida sites.

### Research Areas (Top 5)

| Health Focus Area | Projects | Estimated Funding |
|-------------------|----------|-------------------|
| Mental/Behavioral Health | 414 | ~$785 million |
| Cardiovascular Diseases | 226 | ~$430 million |
| Cancer | 223 | ~$425 million |
| Respiratory Diseases | 171 | ~$325 million |
| Nutritional/Metabolic Disorders | 171 | ~$325 million |

### Recent Award Examples (Relevant to FIU/NeighborhoodHELP)

| Project Focus | Amount | Institution | Relevance |
|--------------|--------|-------------|-----------|
| CHW diabetes management | $3.2M | Johns Hopkins | Model for CHW intervention studies |
| SDOH screening implementation | $5.8M | Kaiser Permanente | SDOH screening in clinical settings |
| Patient navigation for cancer screening | $4.1M | University of Pennsylvania | Navigation program comparison |
| Mobile health for hypertension | $2.9M | Northwestern | Mobile health technology CER |
| AI for patient-reported outcomes | $650K | Duke University | AI/ML methods development |

*Source: PCORI Portfolio Database searches (Retrieved: 2026-02-03)*

### Funding Success Indicators

**Estimated Application Statistics:**
- LOI Submission Rate: 400-600 per cycle
- LOI to Full Application Invitation: ~30-40%
- Full Application Funding Rate: ~20-30%
- Overall Success Rate: ~6-12%

**Factors Associated with Success:**
1. Strong patient engagement plan with demonstrated meaningful engagement
2. Clear comparative design with well-justified comparators
3. Patient-centered outcomes as primary endpoints
4. Methodological rigor and adherence to PCORI Methodology Standards
5. Stakeholder diversity and representative involvement
6. Feasibility evidence (preliminary data, team experience)
7. Health equity lens where applicable
8. Prior PCORI engagement or relationship

---

## Strategic Alignment with FIU Programs

### NeighborhoodHELP Alignment

**Strengths:**
- Community-driven model with CHWs aligns with PCORI's patient engagement requirements
- Service to underserved Miami-Dade populations addresses health equity priority
- Mobile health delivery platform creates real-world pragmatic study setting
- Existing community partnerships provide ready-made stakeholder base
- Track record of patient-centered care delivery

**Potential Study Concepts:**
1. **CHW Navigation Models**: Compare different CHW training levels, functions, or integration approaches
2. **SDOH Screening Implementation**: Compare FIU Thrive-enhanced vs. standard SDOH screening
3. **Closed-Loop Referral Systems**: Compare technology-enabled vs. manual referral tracking
4. **Care Coordination Interventions**: Compare different models of care coordination for patients with multiple chronic conditions

### FIU Thrive Alignment

**Strengths:**
- AI-enhanced SDOH screening aligns with PCORI's AI/ML methods priority
- Platform generates comparative effectiveness data (enhanced vs. standard screening)
- Technology enables scalable, pragmatic implementation
- Patient-centered design with focus on actionable outcomes
- Potential for health equity impact through improved SDOH identification

**Potential Study Concepts:**
1. **AI/ML Methods Development**: Validate FIU Thrive algorithms for SDOH identification accuracy
2. **Comparative Effectiveness Trial**: Thrive-enhanced care vs. standard SDOH screening and referral
3. **Implementation Study**: Different strategies for integrating Thrive into clinical workflows
4. **Patient-Reported Outcomes**: Compare patient satisfaction and experience with AI-enhanced vs. standard screening

### Recommended Entry Strategy

**Phase 1 (2026): Capacity Building**
- **Program**: Engagement Award (Capacity Building)
- **Amount**: $250,000-$300,000
- **Duration**: 2 years
- **Purpose**:
  - Establish patient advisory board from NeighborhoodHELP service population
  - Build capacity for patient-centered research
  - Develop relationships with PCORI program officers
  - Pilot engagement approaches for future research proposals

**Phase 2 (2027): Methods Development**
- **Program**: Methods PFA (AI/ML)
- **Amount**: $500,000-$750,000
- **Duration**: 3 years
- **Purpose**:
  - Validate FIU Thrive AI/ML algorithms
  - Develop patient-centered implementation approaches
  - Build evidence base for larger pragmatic trial
  - Publish methodology papers establishing credibility

**Phase 3 (2028-2032): Pragmatic Trial**
- **Program**: Broad Pragmatic Studies (Category 1 or 2)
- **Amount**: $5M-$12M
- **Duration**: 5 years
- **Purpose**:
  - Compare FIU Thrive-enhanced care vs. standard care
  - Multi-site implementation across Miami-Dade safety-net settings
  - Patient-centered outcomes (SDOH needs addressed, health service utilization, patient satisfaction)
  - Dissemination and implementation planning

**Total Potential PCORI Investment**: $5.75M - $13.05M over 7 years

### Risk Mitigation

**Key Challenges:**
- High competition (6-12% overall success rate)
- Extensive patient engagement infrastructure required
- 12-18 month application timeline
- Rigorous methodology standards compliance
- No prior PCORI relationship

**Mitigation Strategies:**
- Start with Engagement Award to build capacity and relationship
- Engage PCORI program officers early for guidance
- Leverage NeighborhoodHELP's existing community partnerships
- Invest in patient advisory board development before LOI
- Partner with institution with prior PCORI success (e.g., UF Health)
- Consider consortium approach for larger applications

---

## Strategic Notes

1. **Patient Engagement is Non-Negotiable**: PCORI's Six Foundational Expectations are strict requirements, not aspirational goals. Applications without genuine patient engagement throughout all phases will be rejected. FIU must establish a patient advisory board before LOI submission, budget adequately for partner compensation, and demonstrate meaningful decision-making roles for patient partners.

2. **Engagement Award as Strategic Entry Point**: The Capacity Building Engagement Award ($100K-$300K) represents an ideal low-risk entry to PCORI funding. This program would support establishment of a patient advisory board, build organizational capacity for patient-centered research, and create a relationship with PCORI program officers. Success here positions FIU for larger research awards.

3. **AI/ML Methods Priority Creates Timely Opportunity**: PCORI's 2026 Methods PFA specifically prioritizes AI/ML applications in CER, directly aligning with FIU Thrive's technology. A methods development award ($500K-$750K) focused on validating Thrive's algorithms would build evidence and credibility before pursuing a larger pragmatic trial.

4. **Comparative Design is Required**: All PCORI research must compare two or more interventions/approaches. FIU Thrive vs. standard SDOH screening creates a natural comparative framework. The key is demonstrating both approaches are clinically legitimate comparators and the choice between them represents genuine uncertainty.

5. **Health Equity Lens Strengthens Competitiveness**: PCORI's National Priority to Achieve Health Equity permeates all funding decisions. NeighborhoodHELP's focus on underserved Miami-Dade communities positions FIU well, but applications must explicitly frame research through health equity lens with measurable disparities outcomes.

6. **Timeline Requires 18+ Month Lead Time**: The two-stage process (LOI then full application) plus 3-4 month review cycle means 12-18 months from initial LOI to award. For Cycle 2 2026 (LOI deadline April 28, 2026), FIU needs to begin preparation immediately to meet deadline.

7. **Methodology Standards Compliance is Complex**: PCORI's 67 methodology standards across 17 areas create significant compliance burden. FIU should engage biostatistician and methodologist early to ensure study design meets applicable standards. The Methodology Standards Checklist is required with full application.

8. **Patient-Centered Outcomes Must Be Primary**: Unlike NIH where clinical outcomes are primary, PCORI requires patient-important outcomes as primary endpoints. For FIU Thrive, this means outcomes like "number of SDOH needs successfully addressed" or "patient satisfaction with care coordination," not just clinical metrics.

9. **Relationship Building with Program Officers**: PCORI encourages applicants to contact program staff before LOI submission. This isn't optional adviceâ€”it's essential strategy. Program officers can provide feedback on concept fit, suggest relevant portfolio studies, and guide methodology approach. Contact pfa@pcori.org to request consultation.

10. **Multi-Institution Partnerships Strengthen Applications**: While not required, partnerships with organizations that have prior PCORI success increase competitiveness. Consider partnering with University of Florida Health (HSII participant) or other Florida institutions with PCORI portfolio presence.

---

## Resources

- **PCORI Official Website**: https://www.pcori.org *(Retrieved: 2026-02-03)*
  - Primary source for organizational information, mission, leadership, and portfolio data

- **PCORI Funding Opportunities**: https://www.pcori.org/funding-opportunities *(Retrieved: 2026-02-03)*
  - Current funding announcements, deadlines, and application requirements for all programs

- **PCORI Online Application Portal**: https://pcori.force.com/s/ *(Retrieved: 2026-02-03)*
  - Submission system for LOIs and full applications; account creation required

- **PCORI Engagement Resources**: https://www.pcori.org/engagement-research/engagement-resources *(Retrieved: 2026-02-03)*
  - Tools, templates, and guidance for patient and stakeholder engagement planning

- **PCORI Research Portfolio**: https://www.pcori.org/explore-our-portfolio *(Retrieved: 2026-02-03)*
  - Searchable database of all funded projects, outcomes, and publications

- **PCORI Methodology Standards**: https://www.pcori.org/research/about-our-research/research-methodology/pcori-methodology-standards *(Retrieved: 2026-02-03)*
  - Complete standards documentation (67 standards across 17 areas) and Methodology Standards Checklist

- **Six Foundational Expectations for Partnerships**: https://www.pcori.org/engagement/six-foundational-expectations-partnerships *(Retrieved: 2026-02-03)*
  - Detailed guidance on patient engagement requirements; updated from 2014 Engagement Rubric

- **PCORnet Information**: https://www.pcori.org/pcornet *(Retrieved: 2026-02-03)*
  - Details on National Patient-Centered Clinical Research Network for Category 3 BPS applications

- **PCORI Funding Announcements Email List**: Sign up at https://www.pcori.org/funding-opportunities *(Retrieved: 2026-02-03)*
  - Receive notifications of new funding opportunities and upcoming deadlines

---

## Appendix: Key Program Officers & Contacts

### General Inquiries
- **Email**: info@pcori.org
- **Phone**: (202) 827-7700
- **Fax**: (202) 355-9558

### Funding Opportunities
- **Email**: pfa@pcori.org
- **Purpose**: Questions about specific funding announcements, LOI guidance, application support

### Engagement Resources
- **Website**: https://www.pcori.org/engagement-research/engagement-resources
- **Purpose**: Support for patient engagement planning, access to tools and templates

### Research Portfolio Inquiries
- **Website**: https://www.pcori.org/explore-our-portfolio
- **Purpose**: Search funded projects, access publications, identify similar research

### Press and Media
- **Website**: https://www.pcori.org/news-media
- **Purpose**: Award announcements, organizational news

---

*Document generated by grant-funder-researcher agent*
*Next review date: 2026-08-03 (6 months)*
*For updates or corrections, re-run agent with verify task*
